U.S. market Closed. Opens in 16 hours 53 minutes

NRXP | NRx Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
RevenueN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue5.00K4.00K2.00K907.41KN/A1.01MN/A
Gross Profit-5.00K-4.00K-2.00K-907.41KN/A-1.01MN/A
Operating Expenses27.58M44.40M94.43M11.90M6.43K1.01MN/A
Selling, General & Admin14.21M27.37M74.94M11.44M2.77KN/AN/A
Research & Development13.37M17.03M20.26M10.62M3.50KN/AN/A
Other Operating Expenses250.00K-505.00K-771.00K-10.16M713.19K1.01MN/A
Operating Income-27.59M-44.40M-115.80M-51.39M-6.26K-1.01MN/A
Other Expenses / Income-2.56M4.58M22.73M-390.00K492.63K1.09MN/A
Before Tax Income-30.15M-39.82M-93.06M-51.78M492.63K82.41KN/A
Income Tax ExpensesN/A-4.58M-21.35M-39.43M84.21K16.31KN/A
Net Income-30.15M-35.23M-71.72M-12.35M408.43K66.10KN/A
Interest Expenses120.00K-4.58M18.00K56.00KN/AN/AN/A
Basic Shares Outstanding7.58M65.77M46.92M34.27M508.83K2.61M2.61M
Diluted Shares Outstanding7.58M65.77M46.92M34.27M508.83K2.61M2.61M
EBITDA-27.58M-44.65M-115.79M-51.38M-6.26K82.41KN/A
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-30.03M-44.40M-93.05M-51.72M492.63K82.41KN/A
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙